Navigation Links
Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences
Date:4/24/2009

-Testimony To Legislature Calls For Rejection Of Legislation That Will Cost Vermonters Current And Future Jobs-

MONTPELIER, Vt., April 24 /PRNewswire/ -- In testimony to the Legislature and a full page ad in today's Rutland Herald, the region's largest biotechnology association warned that a bill under consideration by the Vermont Legislature will create the most restrictive and onerous regulatory environment for biotechnology growth and development not only in New England, but in the entire nation. S. 48/H. 270 is the subject of a hearing in Montpelier today.

"Plain and simple, this legislation will harm Vermont's biotechnology and life sciences sector and drive jobs away," said Paula Newton, Chair of the New England Biotech Association (NEBA).

NEBA serves as the regional policy and public affairs voice for the biotechnology and biopharmaceutical community, representing state biotech associations, companies, academic institutions, and other organizations consisting of more than 800 entities.

"Vermont already has one of the strictest pharmaceutical marketing disclosure laws in the country, so the onerous regulatory regime contemplated by the Legislation is wholly unnecessary and should be defeated," continued Newton. "Physicians are trusted professionals, and introducing unreasonably broad controls and prohibitions on the interactions between the biopharmaceutical industry and doctors is unwarranted and contrary to health interests of Vermonters who stand to benefit from miracle drugs." She said the legislation would also eliminate existing protections of trade secrets, create an unneeded new state bureaucracy, and drive away research funding by mandating additional disclosure of expenditures.

Four other states, including New England states Maine and Rhode Island, have recently rejected marketing restriction legislation far less extreme than the Vermont bill, declaring the measures as bad policy with negative consequences for the life sciences industry and the jobs it produces. An overly restrictive disclosure law recently passed in Massachusetts --- less strict than the Vermont proposal -- has resulted in a drop in clinical trials and the cancellation of a major medical convention and the associated tourism and tax revenue.

NEBA is a non-profit, member-driven organization comprised of state biotech associations, companies, academic institutions, and other organizations with a collective mission to support and grow the biotechnology industry in New England.

To find out more about NEBA and view a copy of the Rutland Herald ad, visit www.newenglandbiotech.org


'/>"/>
SOURCE New England Biotech Association
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009
2. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
3. Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
4. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
5. New Regional Biotech Association Formed
6. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
7. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
8. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
9. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
10. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
11. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016  BD (Becton, Dickinson and Company) (NYSE: ... announced the launch of the BD CLiC™ System during ... Meeting. --> --> ... providing cost effective NGS library preparation with limited operator ... integrated, next generation sequencing (NGS) library prep instrument, engineered ...
(Date:2/11/2016)... Inc. (NASDAQ: NBIX ) today announced its financial results for ... --> --> For the fourth quarter of ... $0.34 loss per share, compared to a net loss of $19.4 ... 2014. For the year ended December 31, 2015, the Company reported ... as compared to a net loss of $60.5 million, or $0.81 ...
(Date:2/11/2016)... -- Spectra BioPharma Selling Solutions (Spectra) is a new ... the experience, expertise, operational delivery and customer focus ... Created in concert with industry leading commercial experts, ... tactical needs of its clients by providing value-based ... and non-personal promotion. --> ...
(Date:2/11/2016)... BEACH, Florida , February 11, 2016 /PRNewswire/ ... PositiveID Corporation ("PositiveID" or "Company") (OTCQB: PSID), ... diagnostics, announced today that its Thermomedics subsidiary, which ... progress on its growth plan in January 2016, ... products distributors, increasing sequential monthly sales growth, and ...
Breaking Biology Technology:
(Date:2/9/2016)... 2016 Vigilant Solutions announces today that an agency ... develop a lead in a difficult homicide case. The agency ... locate the suspect vehicle. Due to the ongoing investigation, the ... omitted at the agency,s request. --> ... victim was found deceased at an intersection here in the ...
(Date:2/3/2016)... --> --> Fourth quarter ... up 1,187% compared with fourth quarter of 2014. Gross margin ... (loss: 30.0). Earnings per share increased to SEK 6.39 (loss: ... (neg: 74.7). , --> --> ... 2,900.5 M (233.6), up 1,142% compared with 2014. Gross margin ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
Breaking Biology News(10 mins):